Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's diseaseMatthieu F. Bastide, Erwan Bézard, Barbara Picconi et al.|Progress in Neurobiology|2015Cited by 472
Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complexJennifer Stanic, Fabrizio Gardoni|Nature Communications|2015Cited by 75
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson’s diseaseElena Ferrari, Fabrizio Gardoni|Pharmacological Research|2022Cited by 27